12649296|t|Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
12649296|a|Galantamine (Reminyl), an approved treatment for Alzheimer's disease (AD), is a potent allosteric potentiating ligand (APL) of human alpha 3 beta 4, alpha 4 beta 2, and alpha 6 beta 4 nicotinic receptors (nAChRs), and of the chicken/mouse chimeric alpha 7/5-hydroxytryptamine3 receptor, as was shown by whole-cell patch-clamp studies of human embryonic kidney-293 cells stably expressing a single nAChR subtype. Galantamine potentiates agonist responses of the four nAChR subtypes studied in the same window of concentrations (i.e., 0.1-1 microM), which correlates with the cerebrospinal fluid concentration of the drug at the recommended daily dosage of 16 to 24 mg. At concentrations >10 microM, galantamine acts as an nAChR inhibitor. The other presently approved AD drugs, donepezil and rivastigmine, are devoid of the nicotinic APL action; at micromolar concentrations they also block nAChR activity. Using five CHO-SRE-Luci cell lines, each of them expressing a different human muscarinic receptor, and a reporter gene assay, we show that galantamine does not alter the activity of M1-M5 receptors, thereby confirming that galantamine modulates selectively the activity of nAChRs. These studies support our previous proposal that the therapeutic action of galantamine is mainly produced by its sensitizing action on nAChRs rather than by general cholinergic enhancement due to cholinesterase inhibition. Galantamine's APL action directly addresses the nicotinic deficit in AD.
12649296	0	11	Galantamine	Chemical	MESH:D005702
12649296	122	133	Galantamine	Chemical	MESH:D005702
12649296	135	142	Reminyl	Chemical	MESH:D005702
12649296	171	190	Alzheimer's disease	Disease	MESH:D000544
12649296	192	194	AD	Disease	MESH:D000544
12649296	241	244	APL	Chemical	-
12649296	249	254	human	Species	9606
12649296	347	354	chicken	Species	9031
12649296	355	360	mouse	Species	10090
12649296	459	464	human	Species	9606
12649296	519	524	nAChR	Gene	1137
12649296	534	545	Galantamine	Chemical	MESH:D005702
12649296	588	593	nAChR	Gene	1137
12649296	820	831	galantamine	Chemical	MESH:D005702
12649296	843	848	nAChR	Gene	1137
12649296	889	891	AD	Disease	MESH:D000544
12649296	899	908	donepezil	Chemical	MESH:D000077265
12649296	913	925	rivastigmine	Chemical	MESH:D000068836
12649296	955	958	APL	Chemical	-
12649296	1012	1017	nAChR	Gene	1137
12649296	1039	1042	CHO	CellLine	CVCL:0213
12649296	1100	1105	human	Species	9606
12649296	1167	1178	galantamine	Chemical	MESH:D005702
12649296	1251	1262	galantamine	Chemical	MESH:D005702
12649296	1384	1395	galantamine	Chemical	MESH:D005702
12649296	1505	1519	cholinesterase	Gene	590
12649296	1532	1543	Galantamine	Chemical	MESH:D005702
12649296	1546	1549	APL	Chemical	-
12649296	1601	1603	AD	Disease	MESH:D000544
12649296	Negative_Correlation	MESH:D000068836	1137
12649296	Negative_Correlation	MESH:D005702	MESH:D000544
12649296	Negative_Correlation	MESH:D000077265	1137
12649296	Negative_Correlation	MESH:D000068836	MESH:D000544
12649296	Negative_Correlation	MESH:D005702	1137
12649296	Negative_Correlation	MESH:D000544	1137
12649296	Negative_Correlation	MESH:D000077265	MESH:D000544

